The Alzheimer's disease mitochondrial cascade hypothesis: An update

Experimental Neurology

Volumn 218, Issue 2, 2009, Pages 308-315

  Swerdlow, Russell H ^a   Khan, Shaharyar M ^b  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b Gencia Corporation   (United States)

Author keywords

Alzheimer's disease; Cybrids; Mitochondria; Mitochondrial cascade hypothesis

Indexed keywords

AGING; ALZHEIMER DISEASE; AUTOSOMAL DOMINANT DISORDER; BRAIN MITOCHONDRION; HISTOPATHOLOGY; HUMAN; HYPOTHESIS; INHERITANCE; PRIORITY JOURNAL; REVIEW; SYMPTOM;

AGING; ALZHEIMER DISEASE; AMYLOIDOSIS; ANIMALS; BRAIN; CELL CYCLE; HUMANS; MITOCHONDRIA; RISK FACTORS; TAU PROTEINS;

EID: 67649687124     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2009.01.011     Document Type: Review

References (135)

1. Aizenstein H.J., Nebes R.D., Saxton J.A., Price J.C., Mathis C.A., Tsopelas N.D., Ziolko S.K., James J.A., Snitz B.E., Houck P.R., Bi W., Cohen A.D., Lopresti B.J., DeKosky S.T., Halligan E.M., and Klunk W.E. Frequent amyloid deposition without significant cognitive impairment among the elderly. Arch. Neurol. 65 (2008) 1509-1517
2. Alvarez V., Corao A.I., Alonso-Montes C., Sanchez-Ferrero E., De Mena L., Morales B., Garcia-Castro M., and Coto E. Mitochondrial transcription factor A (TFAM) gene variation and risk of late-onset Alzheimer's disease. J. Alzheimers Dis. 13 (2008) 275-280
3. Anandatheerthavarada H.K., and Devi L. Amyloid precursor protein and mitochondrial dysfunction in Alzheimer's disease. Neuroscientist 13 (2007) 626-638
4. Anandatheerthavarada H.K., Biswas G., Robin M.A., and Avadhani N.G. Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells. J. Cell Biol. 161 (2003) 41-54
5. Arendt T., Holzer M., Stobe A., Gartner U., Luth H.J., Bruckner M.K., and Ueberham U. Activated mitogenic signaling induces a process of dedifferentiation in Alzheimer's disease that eventually results in cell death. Ann. N.Y. Acad. Sci. 920 (2000) 249-255
6. Arendt T., Stieler J., Strijkstra A.M., Hut R.A., Rudiger J., Van der Zee E.A., Harkany T., Holzer M., and Hartig W. Reversible paired helical filament-like phosphorylation of tau is an adaptive process associated with neuronal plasticity in hibernating animals. J. Neurosci. 23 (2003) 6972-6981
7. Baker M., Litvan I., Houlden H., Adamson J., Dickson D., Perez-Tur J., Hardy J., Lynch T., Bigio E., and Hutton M. Association of an extended haplotype in the tau gene with progressive supranuclear palsy. Hum. Mol. Genet. 8 (1999) 711-715
8. Baloyannis S.J. Mitochondrial alterations in Alzheimer's disease. J. Alzheimers Dis. 9 (2006) 119-126
9. Barrientos A., Casademont J., Cardellach F., Estivill X., Urbano-Marquez A., and Nunes V. Reduced steady-state levels of mitochondrial RNA and increased mitochondrial DNA amount in human brain with aging. Brain Res. Mol. Brain Res. 52 (1997) 284-289
10. Bekris L.M., Millard S.P., Galloway N.M., Vuletic S., Albers J.J., Li G., Galasko D.R., DeCarli C., Farlow M.R., Clark C.M., Quinn J.F., Kaye J.A., Schellenberg G.D., Tsuang D., Peskind E.R., and Yu C.E. Multiple SNPs within and surrounding the apolipoprotein E gene influence cerebrospinal fluid apolipoprotein E protein levels. J. Alzheimers Dis. 13 (2008) 255-266
11. Belin A.C., Bjork B.F., Westerlund M., Galter D., Sydow O., Lind C., Pernold K., Rosvall L., Hakansson A., Winblad B., Nissbrandt H., Graff C., and Olson L. Association study of two genetic variants in mitochondrial transcription factor A (TFAM) in Alzheimer's and Parkinson's disease. Neurosci. Lett. 420 (2007) 257-262
12. Bhat R.V., and Budd S.L. GSK3beta signalling: casting a wide net in Alzheimer's disease. Neurosignals 11 (2002) 251-261
13. Billingsley M.L., and Kincaid R.L. Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration. Biochem. J. 323 Pt 3 (1997) 577-591
14. Blalock E.M., Geddes J.W., Chen K.C., Porter N.M., Markesbery W.R., and Landfield P.W. Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 2173-2178
15. Blass J.P., Baker A.C., Ko L., and Black R.S. Induction of Alzheimer antigens by an uncoupler of oxidative phosphorylation. Arch. Neurol. 47 (1990) 864-869
16. Bondy C.A., and Cheng C.M. Signaling by insulin-like growth factor 1 in brain. Eur. J. Pharmacol. 490 (2004) 25-31
17. Cairns N.J., Bigio E.H., Mackenzie I.R., Neumann M., Lee V.M., Hatanpaa K.J., White III C.L., Schneider J.A., Grinberg L.T., Halliday G., Duyckaerts C., Lowe J.S., Holm I.E., Tolnay M., Okamoto K., Yokoo H., Murayama S., Woulfe J., Munoz D.G., Dickson D.W., Ince P.G., Trojanowski J.Q., and Mann D.M. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol. 114 (2007) 5-22
18. Canevari L., Clark J.B., and Bates T.E. beta-Amyloid fragment 25-35 selectively decreases complex IV activity in isolated mitochondria. FEBS Lett. 457 (1999) 131-134
19. Cardoso S.M., Santos S., Swerdlow R.H., and Oliveira C.R. Functional mitochondria are required for amyloid beta-mediated neurotoxicity. FASEB J. 15 (2001) 1439-1441
20. Cardoso S.M., Santana I., Swerdlow R.H., and Oliveira C.R. Mitochondria dysfunction of Alzheimer's disease cybrids enhances Abeta toxicity. J. Neurochem. 89 (2004) 1417-1426
21. Caspersen C., Wang N., Yao J., Sosunov A., Chen X., Lustbader J.W., Xu H.W., Stern D., McKhann G., and Yan S.D. Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease. FASEB J. 19 (2005) 2040-2041
22. Cassarino D.S., Swerdlow R.H., Parks J.K., Parker Jr. W.D., and Bennett Jr. J.P. Cyclosporin A increases resting mitochondrial membrane potential in SY5Y cells and reverses the depressed mitochondrial membrane potential of Alzheimer's disease cybrids. Biochem. Biophys. Res. Commun. 248 (1998) 168-173
23. Chandrasekaran K., Giordano T., Brady D.R., Stoll J., Martin L.J., and Rapoport S.I. Impairment in mitochondrial cytochrome oxidase gene expression in Alzheimer disease. Brain Res. Mol. Brain Res. 24 (1994) 336-340
24. Chang S., ran Ma T., Miranda R.D., Balestra M.E., Mahley R.W., and Huang Y. Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 18694-18699
25. Cohen P., and Frame S. The renaissance of GSK3. Nat. Rev. Mol. Cell. Biol. 2 (2001) 769-776
26. Colurso G.J., Nilson J.E., and Vervoort L.G. Quantitative assessment of DNA fragmentation and beta-amyloid deposition in insular cortex and midfrontal gyrus from patients with Alzheimer's disease. Life Sci. 73 (2003) 1795-1803
27. Coon K.D., Valla J., Szelinger S., Schneider L.E., Niedzielko T.L., Brown K.M., Pearson J.V., Halperin R., Dunckley T., Papassotiropoulos A., Caselli R.J., Reiman E.M., and Stephan D.A. Quantitation of heteroplasmy of mtDNA sequence variants identified in a population of AD patients and controls by array-based resequencing. Mitochondrion 6 (2006) 194-210
28. Cooper C.E., and Brown G.C. The inhibition of mitochondrial cytochrome oxidase by the gases carbon monoxide, nitric oxide, hydrogen cyanide and hydrogen sulfide: chemical mechanism and physiological significance. J. Bioenerg. Biomembr. (2008) PMID: 18839291
29. Cornwell III G.G., and Westermark P. Senile amyloidosis: a protean manifestation of the aging process. J. Clin. Pathol. 33 (1980) 1146-1152
30. Corral-Debrinski M., Horton T., Lott M.T., Shoffner J.M., McKee A.C., Beal M.F., Graham B.H., and Wallace D.C. Marked changes in mitochondrial DNA deletion levels in Alzheimer brains. Genomics 23 (1994) 471-476
31. Coskun P.E., Beal M.F., and Wallace D.C. Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 10726-10731
32. Cotman C.W. Apoptosis decision cascades and neuronal degeneration in Alzheimer's disease. Neurobiol. Aging 19 (1998) S29-32
33. Crouch P.J., Blake R., Duce J.A., Ciccotosto G.D., Li Q.X., Barnham K.J., Curtain C.C., Cherny R.A., Cappai R., Dyrks T., Masters C.L., and Trounce I.A. Copper-dependent inhibition of human cytochrome c oxidase by a dimeric conformer of amyloid-beta1-42. J. Neurosci. 25 (2005) 672-679
34. Davis R.E., Miller S., Herrnstadt C., Ghosh S.S., Fahy E., Shinobu L.A., Galasko D., Thal L.J., Beal M.F., Howell N., and Parker Jr. W.D. Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 4526-4531
35. de la Monte S.M., Luong T., Neely T.R., Robinson D., and Wands J.R. Mitochondrial DNA damage as a mechanism of cell loss in Alzheimer's disease. Lab. Invest. 80 (2000) 1323-1335
36. Devi L., Prabhu B.M., Galati D.F., Avadhani N.G., and Anandatheerthavarada H.K. Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction. J. Neurosci. 26 (2006) 9057-9068
37. Diana A., Simic G., Sinforiani E., Orru N., Pichiri G., and Bono G. Mitochondria morphology and DNA content upon sublethal exposure to beta-amyloid(1-42) peptide. Coll. Antropol. 32 Suppl. 1 (2008) 51-58
38. Domingues A.F., Arduino D.M., Esteves A.R., Swerdlow R.H., Oliveira C.R., and Cardoso S.M. Mitochondria and ubiquitin-proteasomal system interplay: relevance to Parkinson's disease. Free Radic. Biol. Med. 45 (2008) 820-825
39. Edland S.D., Silverman J.M., Peskind E.R., Tsuang D., Wijsman E., and Morris J.C. Increased risk of dementia in mothers of Alzheimer's disease cases: evidence for maternal inheritance. Neurology 47 (1996) 254-256
40. Escobar-Khondiker M., Hollerhage M., Muriel M.P., Champy P., Bach A., Depienne C., Respondek G., Yamada E.S., Lannuzel A., Yagi T., Hirsch E.C., Oertel W.H., Jacob R., Michel P.P., Ruberg M., and Hoglinger G.U. Annonacin, a natural mitochondrial complex I inhibitor, causes tau pathology in cultured neurons. J. Neurosci. 27 (2007) 7827-7837
41. Flierl A., Reichmann H., and Seibel P. Pathophysiology of the MELAS 3243 transition mutation. J. Biol. Chem. 272 (1997) 27189-27196
42. Fukui H., Diaz F., Garcia S., and Moraes C.T. Cytochrome c oxidase deficiency in neurons decreases both oxidative stress and amyloid formation in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 14163-14168
43. Gabuzda D., Busciglio J., Chen L.B., Matsudaira P., and Yankner B.A. Inhibition of energy metabolism alters the processing of amyloid precursor protein and induces a potentially amyloidogenic derivative. J. Biol. Chem. 269 (1994) 13623-13628
44. Galvan V., Gorostiza O.F., Banwait S., Ataie M., Logvinova A.V., Sitaraman S., Carlson E., Sagi S.A., Chevallier N., Jin K., Greenberg D.A., and Bredesen D.E. Reversal of Alzheimer's-like pathology and behavior in human APP transgenic mice by mutation of Asp664. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 7130-7135
45. Gasparini L., Racchi M., Benussi L., Curti D., Binetti G., Bianchetti A., Trabucchi M., and Govoni S. Effect of energy shortage and oxidative stress on amyloid precursor protein metabolism in COS cells. Neurosci. Lett. 231 (1997) 113-117
46. Goate A., Chartier-Harlin M.C., Mullan M., Brown J., Crawford F., Fidani L., Giuffra L., Haynes A., Irving N., James L., et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349 (1991) 704-706
47. Grimes C.A., and Jope R.S. The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog. Neurobiol. 65 (2001) 391-426
48. Gunther C., von Hadeln K., Muller-Thomsen T., Alberici A., Binetti G., Hock C., Nitsch R.M., Stoppe G., Reiss J., Gal A., and Finckh U. Possible association of mitochondrial transcription factor A (TFAM) genotype with sporadic Alzheimer disease. Neurosci. Lett. 369 (2004) 219-223
49. Haan M.N. Therapy Insight: type 2 diabetes mellitus and the risk of late-onset Alzheimer's disease. Nat. Clin. Pract. Neurol. 2 (2006) 159-166
50. Haass C., and Steiner H. Protofibrils, the unifying toxic molecule of neurodegenerative disorders?. Nat. Neurosci. 4 (2001) 859-860
51. Hansson C.A., Frykman S., Farmery M.R., Tjernberg L.O., Nilsberth C., Pursglove S.E., Ito A., Winblad B., Cowburn R.F., Thyberg J., and Ankarcrona M. Nicastrin, presenilin, APH-1, and PEN-2 form active gamma-secretase complexes in mitochondria. J. Biol. Chem. 279 (2004) 51654-51660
52. Hansson Petersen C.A., Alikhani N., Behbahani H., Wiehager B., Pavlov P.F., Alafuzoff I., Leinonen V., Ito A., Winblad B., Glaser E., and Ankarcrona M. The amyloid beta-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 13145-13150
53. Hardy J.A., and Higgins G.A. Alzheimer's disease: the amyloid cascade hypothesis. Science 256 (1992) 184-185
54. Hardy J., and Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297 (2002) 353-356
55. Hartig W., Stieler J., Boerema A.S., Wolf J., Schmidt U., Weissfuss J., Bullmann T., Strijkstra A.M., and Arendt T. Hibernation model of tau phosphorylation in hamsters: selective vulnerability of cholinergic basal forebrain neurons - implications for Alzheimer's disease. Eur. J. Neurosci. 25 (2007) 69-80
56. Herrup K., and Arendt T. Re-expression of cell cycle proteins induces neuronal cell death during Alzheimer's disease. J. Alzheimers Dis. 4 (2002) 243-247
57. Hirai K., Aliev G., Nunomura A., Fujioka H., Russell R.L., Atwood C.S., Johnson A.B., Kress Y., Vinters H.V., Tabaton M., Shimohama S., Cash A.D., Siedlak S.L., Harris P.L., Jones P.K., Petersen R.B., Perry G., and Smith M.A. Mitochondrial abnormalities in Alzheimer's disease. J. Neurosci. 21 (2001) 3017-3023
58. Holmes C., Boche D., Wilkinson D., Yadegarfar G., Hopkins V., Bayer A., Jones R.W., Bullock R., Love S., Neal J.W., Zotova E., and Nicoll J.A. Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial. Lancet 372 (2008) 216-223
59. Hresko R.C., and Mueckler M. mTOR.RICTOR is the Ser473 kinase for Akt/protein kinase B in 3T3-L1 adipocytes. J. Biol. Chem. 280 (2005) 40406-40416
60. Johnson G.V., and Hartigan J.A. Tau protein in normal and Alzheimer's disease brain: an update. J. Alzheimers Dis. 1 (1999) 329-351
61. Khan S.M., Cassarino D.S., Abramova N.N., Keeney P.M., Borland M.K., Trimmer P.A., Krebs C.T., Bennett J.C., Parks J.K., Swerdlow R.H., Parker Jr. W.D., and Bennett Jr. J.P. Alzheimer's disease cybrids replicate beta-amyloid abnormalities through cell death pathways. Ann. Neurol. 48 (2000) 148-155
62. King M.P., and Attardi G. Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation. Science 246 (1989) 500-503
63. Kish S.J., Bergeron C., Rajput A., Dozic S., Mastrogiacomo F., Chang L.J., Wilson J.M., DiStefano L.M., and Nobrega J.N. Brain cytochrome oxidase in Alzheimer's disease. J. Neurochem. 59 (1992) 776-779
64. Kish S.J., Mastrogiacomo F., Guttman M., Furukawa Y., Taanman J.W., Dozic S., Pandolfo M., Lamarche J., DiStefano L., and Chang L.J. Decreased brain protein levels of cytochrome oxidase subunits in Alzheimer's disease and in hereditary spinocerebellar ataxia disorders: a nonspecific change?. J. Neurochem. 72 (1999) 700-707
65. Kujoth G.C., Hiona A., Pugh T.D., Someya S., Panzer K., Wohlgemuth S.E., Hofer T., Seo A.Y., Sullivan R., Jobling W.A., Morrow J.D., Van Remmen H., Sedivy J.M., Yamasoba T., Tanokura M., Weindruch R., Leeuwenburgh C., and Prolla T.A. Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science 309 (2005) 481-484
66. Lesne S., Koh M.T., Kotilinek L., Kayed R., Glabe C.G., Yang A., Gallagher M., and Ashe K.H. A specific amyloid-beta protein assembly in the brain impairs memory. Nature 440 (2006) 352-357
67. Levy-Lahad E., Wasco W., Poorkaj P., Romano D.M., Oshima J., Pettingell W.H., Yu C.E., Jondro P.D., Schmidt S.D., Wang K., et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269 (1995) 973-977
68. Li F., Calingasan N.Y., Yu F., Mauck W.M., Toidze M., Almeida C.G., Takahashi R.H., Carlson G.A., Flint Beal M., Lin M.T., and Gouras G.K. Increased plaque burden in brains of APP mutant MnSOD heterozygous knockout mice. J. Neurochem. 89 (2004) 1308-1312
69. Lin M.T., Simon D.K., Ahn C.H., Kim L.M., and Beal M.F. High aggregate burden of somatic mtDNA point mutations in aging and Alzheimer's disease brain. Hum. Mol. Genet. 11 (2002) 133-145
70. Lovestone S., and Reynolds C.H. The phosphorylation of tau: a critical stage in neurodevelopment and neurodegenerative processes. Neuroscience 78 (1997) 309-324
71. Lustbader J.W., Cirilli M., Lin C., Xu H.W., Takuma K., Wang N., Caspersen C., Chen X., Pollak S., Chaney M., Trinchese F., Liu S., Gunn-Moore F., Lue L.F., Walker D.G., Kuppusamy P., Zewier Z.L., Arancio O., Stern D., Yan S.S., and Wu H. ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease. Science 304 (2004) 448-452
72. Mancuso M., Coppede F., Murri L., and Siciliano G. Mitochondrial cascade hypothesis of Alzheimer's disease: myth or reality?. Antioxid. Redox Signal. 9 (2007) 1631-1646
73. Manczak M., Park B.S., Jung Y., and Reddy P.H. Differential expression of oxidative phosphorylation genes in patients with Alzheimer's disease: implications for early mitochondrial dysfunction and oxidative damage. Neuromolecular Med. 5 (2004) 147-162
74. Manczak M., Anekonda T.S., Henson E., Park B.S., Quinn J., and Reddy P.H. Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression. Hum. Mol. Genet. 15 (2006) 1437-1449
75. Manning B.D., and Cantley L.C. AKT/PKB signaling: navigating downstream. Cell 129 (2007) 1261-1274
76. Mattson M.P. Apoptosis in neurodegenerative disorders. Nat. Rev., Mol. Cell. Biol. 1 (2000) 120-129
77. McShea A., Harris P.L., Webster K.R., Wahl A.F., and Smith M.A. Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease. Am. J. Pathol. 150 (1997) 1933-1939
78. McShea A., Lee H.G., Petersen R.B., Casadesus G., Vincent I., Linford N.J., Funk J.O., Shapiro R.A., and Smith M.A. Neuronal cell cycle re-entry mediates Alzheimer disease-type changes. Biochim. Biophys. Acta 1772 (2007) 467-472
79. Mecocci P., MacGarvey U., Kaufman A.E., Koontz D., Shoffner J.M., Wallace D.C., and Beal M.F. Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain. Ann. Neurol. 34 (1993) 609-616
80. Mecocci P., MacGarvey U., and Beal M.F. Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann. Neurol. 36 (1994) 747-751
81. Mosch B., Morawski M., Mittag A., Lenz D., Tarnok A., and Arendt T. Aneuploidy and DNA replication in the normal human brain and Alzheimer's disease. J. Neurosci. 27 (2007) 6859-6867
82. Mosconi L., Brys M., Switalski R., Mistur R., Glodzik L., Pirraglia E., Tsui W., De Santi S., and de Leon M.J. Maternal family history of Alzheimer's disease predisposes to reduced brain glucose metabolism. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 19067-19072
83. Mukherjee O., Kauwe J.S., Mayo K., Morris J.C., and Goate A.M. Haplotype-based association analysis of the MAPT locus in late onset Alzheimer's disease. BMC Genet. 8 (2007) 3
84. Nagy Z., Esiri M.M., Cato A.M., and Smith A.D. Cell cycle markers in the hippocampus in Alzheimer's disease. Acta Neuropathol. 94 (1997) 6-15
85. Navarro A., and Boveris A. The mitochondrial energy transduction system and the aging process. Am. J. Physiol. Cell Physiol. 292 (2007) C670-C686
86. Nunomura A., Perry G., Aliev G., Hirai K., Takeda A., Balraj E.K., Jones P.K., Ghanbari H., Wataya T., Shimohama S., Chiba S., Atwood C.S., Petersen R.B., and Smith M.A. Oxidative damage is the earliest event in Alzheimer disease. J. Neuropathol. Exp. Neurol. 60 (2001) 759-767
87. Ott A., Stolk R.P., van Harskamp F., Pols H.A., Hofman A., and Breteler M.M. Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology 53 (1999) 1937-1942
88. Parker Jr. W.D., Filley C.M., and Parks J.K. Cytochrome oxidase deficiency in Alzheimer's disease. Neurology 40 (1990) 1302-1303
89. Parker Jr. W.D., and Parks J.K. Cytochrome c oxidase in Alzheimer's disease brain: purification and characterization. Neurology 45 (1995) 482-486
90. Pereira C., Santos M.S., and Oliveira C. Mitochondrial function impairment induced by amyloid beta-peptide on PC12 cells. Neuroreport 9 (1998) 1749-1755
91. Pittman A.M., Fung H.C., and de Silva R. Untangling the tau gene association with neurodegenerative disorders. Hum. Mol. Genet. 15 Spec No 2 (2006) R188-R195
92. Prick M.J., Gabreels F.J., Trijbels J.M., Janssen A.J., le Coultre R., van Dam K., Jaspar H.H., Ebels E.J., and Op de Coul A.A. Progressive poliodystrophy (Alpers' disease) with a defect in cytochrome aa3 in muscle: a report of two unrelated patients. Clin. Neurol. Neurosurg. 85 (1983) 57-70
93. Ravid M., Gafni J., Sohar E., and Missmahl H.P. Incidence and origin of non-systemic microdeposits of amyloid. J. Clin. Pathol. 20 (1967) 15-20
94. Reddy P.H., McWeeney S., Park B.S., Manczak M., Gutala R.V., Partovi D., Jung Y., Yau V., Searles R., Mori M., and Quinn J. Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: up-regulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer's disease. Hum. Mol. Genet. 13 (2004) 1225-1240
95. Reiman E.M., Caselli R.J., Yun L.S., Chen K., Bandy D., Minoshima S., Thibodeau S.N., and Osborne D. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N. Engl. J. Med. 334 (1996) 752-758
96. Rohn T.T., Rissman R.A., Davis M.C., Kim Y.E., Cotman C.W., and Head E. Caspase-9 activation and caspase cleavage of tau in the Alzheimer's disease brain. Neurobiol. Dis. 11 (2002) 341-354
97. Roses A.D., Saunders A.M., Huang Y., Strum J., Weisgraber K.H., and Mahley R.W. Complex disease-associated pharmacogenetics: drug efficacy, drug safety, and confirmation of a pathogenetic hypothesis (Alzheimer's disease). Pharmacogenomics J. 7 (2007) 10-28
98. Saelens X., Festjens N., Vande Walle L., van Gurp M., van Loo G., and Vandenabeele P. Toxic proteins released from mitochondria in cell death. Oncogene 23 (2004) 2861-2874
99. Sarbassov D.D., Guertin D.A., Ali S.M., and Sabatini D.M. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307 (2005) 1098-1101
100. Sarbassov D.D., Ali S.M., and Sabatini D.M. Growing roles for the mTOR pathway. Curr. Opin. Cell Biol. 17 (2005) 596-603
101. Scheuner D., Eckman C., Jensen M., Song X., Citron M., Suzuki N., Bird T.D., Hardy J., Hutton M., Kukull W., Larson E., Levy-Lahad E., Viitanen M., Peskind E., Poorkaj P., Schellenberg G., Tanzi R., Wasco W., Lannfelt L., Selkoe D., and Younkin S. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat. Med. 2 (1996) 864-870
102. Schieke S.M., and Finkel T. Mitochondrial signaling, TOR, and life span. Biol. Chem. 387 (2006) 1357-1361
103. Schwartz P. New patho-anatomic observations on amyloidosis in the aged. Fluorescence microscopic investigations. In: Mandema E., Ruinen L., Scholten J.H., and Cohen A.S. (Eds). Amyloidosis (1968), Excerpta MedicaFoundation, Amsterdam 400-417
104. Shankar G.M., Li S., Mehta T.H., Garcia-Munoz A., Shepardson N.E., Smith I., Brett F.M., Farrell M.A., Rowan M.J., Lemere C.A., Regan C.M., Walsh D.M., Sabatini B.L., and Selkoe D.J. Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat. Med. 14 (2008) 837-842
105. Sherrington R., Rogaev E.I., Liang Y., Rogaeva E.A., Levesque G., Ikeda M., Chi H., Lin C., Li G., Holman K., et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375 (1995) 754-760
106. Simon D.K., Lin M.T., Zheng L., Liu G.J., Ahn C.H., Kim L.M., Mauck W.M., Twu F., Beal M.F., and Johns D.R. Somatic mitochondrial DNA mutations in cortex and substantia nigra in aging and Parkinson's disease. Neurobiol. Aging 25 (2004) 71-81
107. Small G.W., Mazziotta J.C., Collins M.T., Baxter L.R., Phelps M.E., Mandelkern M.A., Kaplan A., La Rue A., Adamson C.F., Chang L., et al. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease. JAMA 273 (1995) 942-947
108. Storkel S., Bohl J., and Schneider H.M. Senile amyloidosis: principles of localization in a heterogeneous form of amyloidosis. Virchows Arch., B Cell Pathol. Incl. Mol. Pathol. 44 (1983) 145-161
109. Su J.H., Anderson A.J., Cummings B.J., and Cotman C.W. Immunohistochemical evidence for apoptosis in Alzheimer's disease. Neuroreport 5 (1994) 2529-2533
110. Swerdlow R.H. Is aging part of Alzheimer's disease, or is Alzheimer's disease part of aging? Neurobiol. Aging 28 (2007) 1465-1480
111. Swerdlow R.H. Pathogenesis of Alzheimer's disease. Clin. Interv. Aging 2 (2007) 347-359
112. Swerdlow R.H. Mitochondria in cybrids containing mtDNA from persons with mitochondriopathies. J. Neurosci. Res 85 (2007) 3416-3428
113. Swerdlow R.H. Treating neurodegeneration by modifying mitochondria: potential solutions to a "complex" problem. Antioxid. Redox Signal. 9 (2007) 1591-1603
114. Swerdlow R.H., and Kish S.J. Mitochondria in Alzheimer's disease. Int. Rev. Neurobiol. 53 (2002) 341-385
115. Swerdlow R.H., and Khan S.M. A "mitochondrial cascade hypothesis" for sporadic Alzheimer's disease. Med. Hypotheses 63 (2004) 8-20
116. Swerdlow R.H., and Khan S. Alzheimer research forum live discussion: a "mitochondrial cascade hypothesis" for sporadic Alzheimer's disease. J. Alzheimers Dis. 8 (2005) 311-315
117. Swerdlow R.H., Parks J.K., Cassarino D.S., Maguire D.J., Maguire R.S., Bennett Jr. J.P., Davis R.E., and Parker Jr. W.D. Cybrids in Alzheimer's disease: a cellular model of the disease?. Neurology 49 (1997) 918-925
118. Swerdlow R.H., Ghosh S., and Wang K.X. Polymorphism-determined variation of the cytochrome oxidase enzyme. Soc. Neurosci. Abstr. 32 (2006) 79.1
119. Szabados T., Dul C., Majtenyi K., Hargitai J., Penzes Z., and Urbanics R. A chronic Alzheimer's model evoked by mitochondrial poison sodium azide for pharmacological investigations. Behav. Brain Res. 154 (2004) 31-40
120. Takuma K., Yan S.S., Stern D.M., and Yamada K. Mitochondrial dysfunction, endoplasmic reticulum stress, and apoptosis in Alzheimer's disease. J. Pharmacol. Sci. 97 (2005) 312-316
121. Teng F.Y., and Tang B.L. Widespread gamma-secretase activity in the cell, but do we need it at the mitochondria? Biochem. Biophys. Res. Commun. 328 (2005) 1-5
122. Trifunovic A., Wredenberg A., Falkenberg M., Spelbrink J.N., Rovio A.T., Bruder C.E., Bohlooly Y.M., Gidlof S., Oldfors A., Wibom R., Tornell J., Jacobs H.T., and Larsson N.G. Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature 429 (2004) 417-423
123. Trimmer P.A., Swerdlow R.H., Parks J.K., Keeney P., Bennett Jr. J.P., Miller S.W., Davis R.E., and Parker Jr. W.D. Abnormal mitochondrial morphology in sporadic Parkinson's and Alzheimer's disease cybrid cell lines. Exp. Neurol. 162 (2000) 37-50
124. Trimmer P.A., Keeney P.M., Borland M.K., Simon F.A., Almeida J., Swerdlow R.H., Parks J.P., Parker Jr. W.D., and Bennett Jr. J.P. Mitochondrial abnormalities in cybrid cell models of sporadic Alzheimer's disease worsen with passage in culture. Neurobiol. Dis. 15 (2004) 29-39
125. Valla J., Schneider L., Niedzielko T., Coon K.D., Caselli R., Sabbagh M.N., Ahern G.L., Baxter L., Alexander G., Walker D.G., and Reiman E.M. Impaired platelet mitochondrial activity in Alzheimer's disease and mild cognitive impairment. Mitochondrion 6 (2006) 323-330
126. van der Walt J.M., Dementieva Y.A., Martin E.R., Scott W.K., Nicodemus K.K., Kroner C.C., Welsh-Bohmer K.A., Saunders A.M., Roses A.D., Small G.W., Schmechel D.E., Murali Doraiswamy P., Gilbert J.R., Haines J.L., Vance J.M., and Pericak- Vance M.A. Analysis of European mitochondrial haplogroups with Alzheimer disease risk. Neurosci. Lett. 365 (2004) 28-32
127. Vermulst M., Wanagat J., Kujoth G.C., Bielas J.H., Rabinovitch P.S., Prolla T.A., and Loeb L.A. DNA deletions and clonal mutations drive premature aging in mitochondrial mutator mice. Nat. Genet. 40 (2008) 392-394
128. Vincent I., Rosado M., and Davies P. Mitotic mechanisms in Alzheimer's disease?. J. Cell Biol. 132 (1996) 413-425
129. Webster M.T., Pearce B.R., Bowen D.M., and Francis P.T. The effects of perturbed energy metabolism on the processing of amyloid precursor protein in PC12 cells. J. Neural Transm. 105 (1998) 839-853
130. Wolf P.A., Beiser A., Au R., Auerbach S., and DeCarli C. Parental Occurrence of Dementia Linked to Lower Cognitive Function in the Framingham Offspring Study. Neurology 64 Suppl 1 (2005) A267-A268
131. Yamaguchi H., Yamazaki T., Ishiguro K., Shoji M., Nakazato Y., and Hirai S. Ultrastructural localization of Alzheimer amyloid beta/A4 protein precursor in the cytoplasm of neurons and senile plaque-associated astrocytes. Acta Neuropathol. 85 (1992) 15-22
132. Yanagisawa M., Planel E., Ishiguro K., and Fujita S.C. Starvation induces tau hyperphosphorylation in mouse brain: implications for Alzheimer's disease. FEBS Lett. 461 (1999) 329-333
133. Yang Y., Geldmacher D.S., and Herrup K. DNA replication precedes neuronal cell death in Alzheimer's disease. J. Neurosci. 21 (2001) 2661-2668
134. Zhang D., Mott J.L., Chang S.W., Stevens M., Mikolajczak P., and Zassenhaus H.P. Mitochondrial DNA mutations activate programmed cell survival in the mouse heart. Am. J. Physiol. Heart Circ. Physiol. 288 (2005) H2476-H2483
135. Zhu X., McShea A., Harris P.L., Raina A.K., Castellani R.J., Funk J.O., Shah S., Atwood C., Bowen R., Bowser R., Morelli L., Perry G., and Smith M.A. Elevated expression of a regulator of the G2/M phase of the cell cycle, neuronal CIP-1-associated regulator of cyclin B, in Alzheimer's disease. J. Neurosci. Res. 75 (2004) 698-703